{"product_id":"olanzaget-tab-3mg-25mg-1-box-2-strips-1-strip-7-tab-specification","title":"OLANZAGET TAB 3mg\/25mg (1 Box = 2 Strips) (1 Strip = 7 TAB) Specification","description":"\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2__mjUHQ\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eRequires Prescription (YES\/NO)\u003c\/h3\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eGenerics\u003c\/h3\u003e\n\u003cp\u003eOlanzapine , Fluoxetine\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eUsed For\u003c\/h3\u003e\n\u003cp\u003eDepression\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eHow it works\u003c\/h3\u003e\n\u003cp\u003eFluoxetine: Inhibits CNS neuron setotonin reuptake with minimal or no effect on norepinephrine or dopamine reuptake; does not bind to alpha-adrenergic, histamine, or cholinergic receptors Olanzapine: Potent antagonist of dopamine 1-3, histamine H1, serotonin 5-HT2A and 5-HT2C, and alpha1-adrenergic receptors; shows moterate antagonism for 5-HT3, and muscarinic M1-5 receptors; binds to GABA-A, benzodiazepine, and beta-adrenergic receptors .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2__mjUHQ\"\u003e\n\u003ch2 class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__lpzz8 css-9l3uo3\"\u003eUsage And Safety\u003c\/h2\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eDosage\u003c\/h3\u003e\n\u003cp\u003eDepression Associated with Bipolar I Disorder : Initial: 25 mg\/6 mg orally daily in evening . If needed, may titrate with 25-50 mg fluoxetine\/6-12 mg olanzapine; not to exceed 75 mg\/18 mg per day . Treatment of Resistant Depression : Initial: 25 mg\/6 mg orally daily in evening . If needed, may titrate with 25-50 mg fluoxetine\/6-12 mg olanzapine; not to exceed 75 mg\/18 mg per day . Hypotensive diathesis, hepatic impairment, or slow metabolism: Initiate with 25 mg\/3 mg to 25 mg\/6 mg orally every day . OR As directed by your physician.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eSide Effects\u003c\/h3\u003e\n\u003cp\u003eChills, neck rigidity, photosensitivity reaction ,vasodilatation , QT-interval prolonged , diarrhea , gastritis, gastroenteritis, nausea and vomiting, peptic ulcer , gastrointestinal hemorrhage, intestinal obstruction, liver fatty deposit, pancreatitis , ecchymosis , anemia, thrombocytopenia , leukopenia, purpura , generalized edema, weight loss , bilirubinemia, creatinine increased, gout , osteoporosis .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eDrug Interactions\u003c\/h3\u003e\n\u003cp\u003eMonoamine Oxidase Inhibitors (MAOI) , CNS Acting Drugs , Serotonergic Drugs , Triptans , Tryptophan , Drugs that Interfere with Hemostasis (e.g., NSAIDs, Aspirin, Warfarin) , Benzodiazepines , Inducers of 1A2 , Inhibitors of CYP1A2 , Pimozide , Carbamazepine , Thioridazine , Tricyclic Antidepressants (TCAs) , Antihypertensive Agents , Levodopa and Dopamine Agonists , Benzodiazepines , Clozapine , Haloperidol , Phenytoin , Lithium , Drugs Tightly Bound to Plasma Proteins , Valproate , Biperiden , Theophylline .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eIndication\u003c\/h3\u003e\n\u003cp\u003eDepressive Episodes Associated with Bipolar I Disorder : It is indicated for the acute treatment of depressive episodes associated with Bipolar I Disorder in adults ; Treatment Resistant Depression : It is indicated for the acute treatment of treatment resistant depression (Major Depressive Disorder in adults who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003eWhen not to Use\u003c\/h3\u003e\n\u003cp\u003eThe use is contraindicated with the following: • Monoamine Oxidase Inhibitors (MAOI) • Pimozide • Thioridazine •Hypersensitive to any of the ingredients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2__mjUHQ\"\u003e\n\u003ch2 class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__lpzz8 css-9l3uo3\"\u003ePrecautions\u003c\/h2\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3___ZqGB\"\u003e\n\u003ch3 class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__y_nDL css-9l3uo3\"\u003ePrecaution\u003c\/h3\u003e\n\u003cp\u003eAll patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Getz Pharma Pakistan","offers":[{"title":"Default Title","offer_id":47903442141414,"sku":null,"price":252.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0801\/6039\/1398\/files\/OlanzagetTablets3mg_25mg_1Box_2Strips_1Strip_7Tablets.png?v=1781875203","url":"https:\/\/www.glitzson.com\/products\/olanzaget-tab-3mg-25mg-1-box-2-strips-1-strip-7-tab-specification","provider":"Glitzson","version":"1.0","type":"link"}